Log in
Enquire now
‌

US Patent 12006369 BCMA chimeric antigen receptors

Patent 12006369 was granted and assigned to 2seventy bio, Inc. on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
2seventy bio, Inc.
2seventy bio, Inc.
0
Current Assignee
2seventy bio, Inc.
2seventy bio, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120063690
Patent Inventor Names
Richard Morgan0
Kevin Friedman0
Date of Patent
June 11, 2024
0
Patent Application Number
165158700
Date Filed
July 18, 2019
0
Patent Citations
‌
US Patent 7067318 Methods for transfecting T cells
0
‌
US Patent 7144575 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 7172869 Methods for transfecting T cells
0
‌
US Patent 7175843 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 7232566 Methods for treating HIV infected subjects
0
‌
US Patent 7754482 Artificial antigen presenting cells and uses therefor
0
‌
US Patent 7977095 Generation and isolation of antigen-specific T cells
0
‌
US Patent 9034324 Anti-BCMA antibodies
0
...
Patent Citations Received
‌
US Patent 12109234 Anti-BCMA CAR T cell compositions
0
Patent Primary Examiner
‌
Brad Duffy
0
Patent abstract

The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12006369 BCMA chimeric antigen receptors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.